SMSbiotech
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1825 Diamond St Ste 101, San Marcos, Cal...Phone Number
(760) 290-3406Website
www.smsbiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About SMSbiotech
SMSbiotech is a San Diego-based biotech company specializing in advancing stem cell research and regenerative medicine through its proprietary Small Mobile Stem (SMS) cell technology. The company focuses on developing innovative treatments for chronic diseases, including Chronic Obstructive Pulmonary Disease (COPD), by utilizing unique adult stem cells derived from human blood. With a mission to democratize adult stem cell technologies, SMSbiotech aims to address the root causes of diseases and improve patients' quality of life. Founded in 2015, the company is committed to revolutionizing the life science industry with its patented technology and collaborative approach.Explore more
SMSbiotech Org Chart
HF
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SMSbiotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when SMSbiotech launches new products
SMSbiotech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if SMSbiotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at SMSbiotech
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SMSbiotech recently announced quarterly report
Check out if SMSbiotech is spiking on competitors!
Funding: Get notified immidiatlly once SMSbiotech has new funding data
Check if SMSbiotech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to SMSbiotech
Compare insights from companies similar to SMSbiotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SMSbiotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SMSbiotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SMSbiotech.
SMSbiotech Tech Stack
A closer look at the technologies used by SMSbiotech
See more technologies
Most Recent Scoops
New Hire
Executive Move
Michael Swartzburg has recently joined the organization as Chief Financial Officer.
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Project
Research & Development, Intellectual Property, Safety, Medical Research, Pharmaceuticals, Clinical Operations
Project
SMSbiotech News & Media
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
SAN MARCOS, Calif.--(BUSINESS WIRE)--SMSbiotech, Inc. is pleased to announce the signing of a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). This is the first CRADA agreement for SMSbiotech, and it represents a significant milestone in the company's efforts to address critical military and civilian medical challenges that have existed for over a century. Under this agreement, SMSbiotech and USAMRICD will conduSMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD
SAN MARCOS, Calif.--(BUSINESS WIRE)--SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD.SMSbiotech Unveils New Patented Stem-Cell Technology Designed to Treat COPD
San Diego, California--(Newsfile Corp. - December 20, 2022) - San Diego-based biotechnology firm, SMSbiotech, has announced the development of a unique treatment that utilizes stem-cell technology in order to stimulate the regeneration of lung tissue. This treatment is being readied as a potential means of tackling Chronic Obstructive Pulmonary Disease (COPD) and other severe lung conditions. At present, COPD is the third leading cause of death across the globe, and the condition leads to destruIn Vitro Gene Expression Study Demonstrates Small Mobile Stem Cells Stimulate Progenitor Lung Cells
SAN DIEGO, March 2, 2021 /PRNewswire/ -- SMSbiotech, Inc. announced today that a recent study on the interaction between Alveolar Type 2 (AT2) cells (lung progenitor cells) and Small Mobile Stem (SMS) cells demonstrates critical changes to the gene expression of the AT2 cells responsible...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding SMSbiotech
Sign Up For FreeTo access detailed company insights
SMSbiotech is a San Diego-based biotech company specializing in advancing stem cell research and regenerative medicine through its proprietary Small Mobile Stem (SMS) cell technology. The company focuses on developing innovative treatments for chronic diseases, including Chronic Obstructive Pulmonary Disease (COPD), by utilizing unique adult stem c... Read More
